Pages with the fewest revisions
Showing below up to 250 results in range #251 to #500.
View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)
- Tumour suppressor gene (1 revision)
- National DRL (1 revision)
- ICRP Publication 25 (1 revision)
- ICRP Publication 31 (1 revision)
- Deterministic effect (1 revision)
- Oxygen enhancement ratio (1 revision)
- ICRP Publication 46 (1 revision)
- Population risk (1 revision)
- ICRP Publication 60 (1 revision)
- Dose modifying factor (1 revision)
- ICRP Publication 75 (1 revision)
- ICRP Publication 9 (1 revision)
- 1934 Recommendations (1 revision)
- Access control (1 revision)
- Registry (1 revision)
- General Information: Radon (1 revision - redirect page)
- ICRP Publication 96 (1 revision)
- Secondary radiation (1 revision)
- Intake (1 revision)
- ICRP Publication 108 (1 revision)
- Brachytherapy (1 revision)
- Standard-size adult (1 revision)
- ICRP Publication 121 (1 revision)
- Case–control study (1 revision)
- ICRP Publication 137 (1 revision)
- ICRP Publication 151 (1 revision)
- National radon survey (1 revision)
- ICRP Publication 26 (1 revision)
- DS86 (1 revision)
- ICRP Publication 32 (1 revision)
- ICRP Publication 47 (1 revision)
- Potential alpha energy concentration (1 revision)
- ICRP Publication 61 (1 revision)
- ICRP Publication 76 (1 revision)
- Equilibrium equivalent concentration (1 revision)
- Expanded radiation field (1 revision)
- 1937 Recommendations (1 revision)
- Redox (1 revision)
- Adventitious source (1 revision)
- ICRP Publication 97 (1 revision)
- Annual intake (1 revision)
- Secretory cells (1 revision)
- Intensity-modulated radiotherapy (1 revision)
- ICRP Publication 109 (1 revision)
- Stem cell (1 revision)
- Kerma approximation (1 revision)
- ICRP Publication 122 (1 revision)
- Targeted effects (1 revision)
- ICRP Publication 138 (1 revision)
- Collimation (1 revision)
- ICRP Publication 152 (1 revision)
- Typical value (1 revision)
- ICRP Publication 27 (1 revision)
- ICRP Publication 33 (1 revision)
- Detriment-adjusted risk (1 revision)
- Particle transport (1 revision)
- ICRP Publication 48 (1 revision)
- Dose-response function (1 revision)
- ICRP Publication 62 (1 revision)
- ICRP Publication 77 (1 revision)
- Equilibrium factor (1 revision)
- 1950 Recommendations (1 revision)
- Relative biological effectiveness (1 revision)
- ICRP Publication 98 (1 revision)
- Backscatter factor (1 revision)
- Somatic effect (1 revision)
- ICRP Publication 10A (1 revision)
- ICRP Publication 123 (1 revision)
- Charged-particle equilibrium (1 revision)
- ICRP Publication 139 (1 revision)
- Tolerance dose (1 revision)
- ICRP Publication 153 (1 revision)
- ICRP Publication 28 (1 revision)
- Occupancy factor (1 revision)
- ICRP Publication 34 (1 revision)
- ICRP Publication 49 (1 revision)
- ICRP Publication 63 (1 revision)
- ICRP Publication 78 (1 revision)
- Elemental dose (1 revision)
- Radon-prone area (1 revision)
- Exposed individuals (1 revision)
- 1954 Recommendations (1 revision)
- Reference Person (1 revision)
- Relative life lost (1 revision)
- ICRP Publication 99 (1 revision)
- Apoptosis (1 revision)
- Security screening (1 revision)
- ICRP Publication 11 (1 revision)
- Stochastic effect (1 revision)
- ICRP Publication 124 (1 revision)
- ICRP Publication 125 (1 revision)
- Teratocarcinoma (1 revision)
- Low dose (1 revision)
- ICRP Publication 14 (1 revision)
- Commissioning (1 revision)
- ICRP Publication 154 (1 revision)
- Cosmic radiation (1 revision)
- ICRP Publication 29 (1 revision)
- ICRP Publication 35 (1 revision)
- ICRP Publication 5 (1 revision)
- Dose-threshold hypothesis (1 revision)
- Potentially lethal damage repair (1 revision)
- ICRP Publication 64 (1 revision)
- ICRP Publication 79 (1 revision)
- 1956 Recommendations (1 revision)
- Activation (1 revision)
- Relative risk (1 revision)
- Ring chromosome (1 revision)
- ICRP Supporting Guidance 2 (1 revision)
- ICRP Publication 1 (1 revision)
- Baseline disease rates (1 revision)
- International Commission on Radiological Protection (1 revision)
- ICRP Publication 110 (1 revision)
- Breakpoint cluster region/abelson (1 revision)
- Lag (1 revision)
- Late normal tissue responses (1 revision)
- ICRP Publication 126 (1 revision)
- ICRP Publication 140 (1 revision)
- ICRP Publication 155 (1 revision)
- ICRP Publication 3 (1 revision)
- Α/β value (1 revision)
- Oncogene (1 revision)
- ICRP Publication 36 (1 revision)
- Dicentric chromosome (1 revision)
- ICRP Publication 50 (1 revision)
- Dose and dose-rate effectiveness factor (1 revision)
- ICRP Publication 65 (1 revision)
- ICRP Publication 8 (1 revision)
- 1959 Decisions (1 revision)
- Relative survival (1 revision)
- Hereditary effect (1 revision)
- ICRP Publication 10 (1 revision)
- Source region (1 revision)
- ICRP Publication 111 (1 revision)
- Latent time/period or latency interval (2 revisions)
- Class SR-2 gases (2 revisions)
- Low level waste (2 revisions)
- Committed equivalent dose (2 revisions)
- Dichotomous (2 revisions)
- Dose rate effectiveness factor (2 revisions)
- Qualified expert (2 revisions)
- Emergency plan (2 revisions)
- Radioactive substance (2 revisions)
- Ethics (2 revisions)
- ALARA (2 revisions)
- Reference biokinetic model (2 revisions)
- Relocation (2 revisions)
- Risk coefficient (2 revisions)
- Hierarchical tissues (2 revisions)
- Area monitoring (2 revisions)
- Individual monitoring (2 revisions)
- Benthic (2 revisions)
- Source term (2 revisions)
- Bronchial region (2 revisions)
- Substantial radiation dose level (2 revisions)
- Clearance (2 revisions)
- Transfer rate (2 revisions)
- Multi-detector computed tomography (2 revisions)
- Deontological Ethics (2 revisions)
- Differentiation (2 revisions)
- Percutaneous coronary intervention (2 revisions)
- Prevailing circumstances (2 revisions)
- Radon Recommendations for Authorities (2 revisions)
- Reference individual (2 revisions)
- Activity (2 revisions)
- Remedial action (2 revisions)
- ICRPædia Guide to Dose Coefficients (2 revisions)
- High level waste (2 revisions)
- Intervention Level (2 revisions)
- Clearance level (2 revisions)
- Lymphatic system (2 revisions)
- Transforming growth factor (2 revisions)
- Pericarditis (2 revisions)
- Dose constraint (2 revisions)
- Principle of application of dose limits (2 revisions)
- Early normal tissue responses (2 revisions)
- Radioactivity (2 revisions)
- Radon Recommendations for Workplaces (2 revisions)
- Reference level (2 revisions)
- Remediation (2 revisions)
- Risk of Exposure to Radon (2 revisions)
- Beta-minus decay (2 revisions)
- South Atlantic anomaly (2 revisions)
- Interventional procedure (2 revisions)
- Lifetime risk (2 revisions)
- Macrophage colony stimulating factor (2 revisions)
- Multiplicative risk projection model (2 revisions)
- Cumulative dose (2 revisions)
- Dose conversion coefficient (2 revisions)
- Edema (2 revisions)
- Excess relative risk (2 revisions)
- Exposure situation (2 revisions)
- Repopulation (2 revisions)
- Growth factor (2 revisions)
- Alimentary tract transfer factor (2 revisions)
- Routine monitoring (2 revisions)
- ICRPædia Guide to Radon (2 revisions)
- Beta-plus decay (2 revisions)
- Special (non-routine) monitoring (2 revisions)
- Calculating Doses from Intakes of Radionuclides (2 revisions)
- Clonogenic cells (2 revisions)
- Threshold dose for tissue reactions (2 revisions)
- Magnetosphere (2 revisions)
- Curie (2 revisions)
- Effect Dose 50 (2 revisions)
- Endogeneous excretion (2 revisions)
- Radiographer (2 revisions)
- Exposure to Radon at Home (2 revisions)
- GATA binding protein 2 (2 revisions)
- Representative organism (non-human biota) (2 revisions)
- ICRPædia Guide to the Basics of Ionising Radiation (2 revisions)
- Hormones (2 revisions)
- Authorization (2 revisions)
- Limitation of dose (2 revisions)
- Clonogenic survival (2 revisions)
- Transmission detection system (2 revisions)
- Multistage tumorigenesis (2 revisions)
- Cytokines (2 revisions)
- Non-sphericity parameter (2 revisions)
- Pharynx (2 revisions)
- Acute radiation syndrome (2 revisions)
- Representative person (2 revisions)
- Safety (2 revisions)
- Hounsfield unit (2 revisions)
- Authorized limit (2 revisions)
- Specific effective energy (2 revisions)
- Cardiac arrhythmias (2 revisions)
- Lineal energy (2 revisions)
- Thyroid blocking (2 revisions)
- Transparency (2 revisions)
- Waste disposal (2 revisions)
- Non-targeted effects (2 revisions)
- Disposal (2 revisions)
- Dose criteria (2 revisions)
- Procedural values (2 revisions)
- Environmental exposure (2 revisions)
- Exempt waste (2 revisions)
- Adaptive response (2 revisions)
- Reproductive integrity (2 revisions)
- Alveolar-interstitial region (2 revisions)
- Safety case (2 revisions)
- Autoimmune disease (2 revisions)
- Slow repair (2 revisions)
- Isotropic geometry (2 revisions)
- ICRP Publication 118 (2 revisions)
- Cardiac valve diseases (2 revisions)
- Linear-non-threshold model (2 revisions)
- Co-expertise (2 revisions)
- Connective tissue (2 revisions)
- Trapped particles (2 revisions)